Linda Tharby

Chief Executive Officer and President

Ms. Tharby is an experienced global medical device industry executive, with a 24-year career with Becton Dickinson and Company (“BD”; NYSE: BDX), a leading medical technology company. Ms. Tharby was a member of the Executive Leadership team of BD that transformed the company from an $8 billion medical supplies company to an $18 billion global medical technology company. With over 20 years of experience in global business leadership roles, Ms. Tharby has been accountable for portfolio innovation and global commercialization across multiple business units. Ms. Tharby also has enterprise change and integration experience, with her most recent role at BD, from July 2018 through December 2020, as the company’s Chief Customer Experience Officer and in her prior role, as the company’s Chief Human Resources Officer, from October 2016 through July 2018, through BD’s $24 billion acquisition and integration of C.R. Bard in 2017. Prior to that, she served at BD as the Executive Vice President and President of the Life Sciences segment, Group President of Preanalytical Systems and BD Biosciences, Worldwide President of Diabetes Care, and Vice President and General Manager of Pharmaceutical Systems. Since 2014, Ms. Tharby has served on the Columbia University School of Public Health Board of Advisors.

Karen Fisher

Chief Financial Officer

Karen Fisher has more than 25 years of financial experience in a variety of industries, most recently serving as the Assistant Controller for a global consumer products company. She has also held roles such as Chief Accounting Officer and Treasurer, and Controller. Ms. Fisher held multiple financial management roles covering financial analysis and reporting, budgeting, forecasting, acquisitions, and cash management. She is thoroughly knowledgeable in compliance with SEC regulation, GAAP, 10Q’s, 10K’s and Sarbanes-Oxley. Ms. Fisher is a Certified Public Accountant and a graduate of Arizona State University with a BS in Accounting.

Manuel Marques

Chief Operating Officer

Manny Marques has an engineering background in FDA Class II & III medical devices. He has a proven history of effectively transferring new products from R&D into manufacturing, while also reducing operating and manufacturing costs of existing products. Mr. Marques is a champion at enhancing operational management via implementation of Lean 6-Sigma Manufacturing techniques. Mr. Marques holds two U.S. patents for cardiovascular medical devices. Manny obtained a BS in Mechanical Engineering Technology and also an MS in Engineering Management from the New Jersey Institute of Technology.

Josh Bennett

Vice President of Strategy and Business Development

Mr. Bennett’s experience spans healthcare product categories, care settings, and end markets, including medical devices / technology, pharmaceuticals, biologics, acute care, and home care. He has been responsible for growth in both U.S. and international markets.

He joins KORU Medical from Salter Labs, a global anesthesia and respiratory medical device manufacturer, where he served as Vice President Sales, Marketing, and Business Development beginning in 2012. Salter Labs merged with SunMed in 2019. Prior to this, he was with Baxter Healthcare, a Fortune 500 diversified global pharmaceutical and device manufacturer. At Baxter he focused on pharmaceuticals and biologics, with an emphasis on product and market development addressing nutrition, hydration, and hemophilia. Mr. Bennett began his career at PwC Consulting (now IBM Global Business Services).

Mr. Bennett received his MBA from the Kellogg School of Management at Northwestern University, where he was a Siebel Scholar and recipient of the Richard M. Clewett Award, and his BBA from Northwood University.

Brian Hertzog

Vice President of Business Development

Brian Hertzog comes to Koru with over 15 years of experience in the drug delivery and medical device space. Most recently he was a business development executive at Nemera, a diversified drug delivery company with inhalation, ENT, ophthalmic, dermal, and parenteral devices (both autoinjectors and on-body wearables). He has deep experience in infusion devices and pharmaceutical packaging, also having held business development roles at Unilife, Schott, and Datwyler.

Christopher Pazdan

Vice President of Quality Assurance and Regulatory Affairs

Chris joins the KORU team from Hillrom where he worked as the Vice President of Quality Assurance. In that role he was responsible for all quality functions for Hillrom’s largest manufacturing division. Prior to that role, Chris was the Vice President of QA/RA where he was responsible for enterprise-wide Design Assurance, Supplier Quality Assurance, Project Management Office, and Software. Chris’ proudest professional accomplishments include working with, leading, and helping build great teams. In addition to these efforts, he enjoys making a difference in the healthcare space and improving outcomes for patients and customers.

Chris received his bachelor’s degree in general engineering from the University of Illinois at Urbana-Champaign. He is a ASQ Certified Six Sigma Black Belt, ASQ Certified Quality Engineer and an ASQ Certified Quality Auditor.

Rob Cannon

Vice President of Sales

Rob brings 30+ years of experience in sales across the healthcare industry with direct experience in home care, specialty pharmacy and with Plasma/Biologics.  Most recently, he served as the Vice President of Strategic Accounts for McKesson Alternate Pharmacy Solutions, where he led the strategy, planning, and implementation of effective sales and marketing strategies focused on the specialty pharma channel. Prior to that role, Rob was the Vice President of Sales for McKesson Plasma and Biologics, where he established and managed a sales team, and as the Senior Director for McKesson Alternate Site Pharmacy, where he spearheaded the development and execution of strategic programs enhancing pharmacy partnerships while also driving value and efficiency. Rob received his Bachelor of Science degree in chemistry from Fordham University. 

Tom Adams

Vice President of Financial Planning and Analysis

Tom joins KORU with medical device industry experience, coming from Integra Life Sciences, where he spent the last 10 years, with his most recent role there as Senior Director of Finance (FP&A).  Previous roles included Group Controller/Head of FP&A and Director of Finance (FP&A). Career highlights include establishing the Finance function for a newly created manufacturing division at Integra, which involved creating processes, setting up systems for reporting, management presentations and hiring a strong team. Tom recently led the financial analysis and negotiation to move Integra’s headquarters to Princeton, NJ, which this deal was recently awarded NJ’s 2019 office real estate deal of the year! He earned his Bachelor of Science in Business Administration-Accounting & Finance from Ohio State University. Tom brings extensive expertise and experience in building forecasts, budgets, modeling, and cost accounting that will support decision making and actions to help drive KORU’s growth.